Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2
Michele Catanzaro, Francesca Fagiani, Marco Racchi, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 599

Showing 1-25 of 599 citing articles:

Of chloroquine and COVID-19
Franck Touret, Xavier de Lamballerie
Antiviral Research (2020) Vol. 177, pp. 104762-104762
Open Access | Times Cited: 551
The signal pathways and treatment of cytokine storm in COVID-19
Lan Yang, Xueru Xie, Zikun Tu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 509
The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
Jin-Yan Li, Ce-Heng Liao, Qiong Wang, et al.
Virus Research (2020) Vol. 286, pp. 198074-198074
Open Access | Times Cited: 475
Impacts of COVID-19 pandemic on urban park visitation: a global analysis
Dehui Christina Geng, John L. Innes, Wanli Wu, et al.
Journal of Forestry Research (2020) Vol. 32, Iss. 2, pp. 553-567
Open Access | Times Cited: 460
Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome
Sonia Villapol
Translational research (2020) Vol. 226, pp. 57-69
Open Access | Times Cited: 339
Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity
Qiangzhe Zhang, Anna N. Honko, Jiarong Zhou, et al.
Nano Letters (2020) Vol. 20, Iss. 7, pp. 5570-5574
Open Access | Times Cited: 310
The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation
Zhihua Bai, Ying Cao, Wenjun Liu, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1115-1115
Open Access | Times Cited: 291
Biomarkers in COVID-19: An Up-To-Date Review
Madhusudan Samprathi, Muralidharan Jayashree
Frontiers in Pediatrics (2021) Vol. 8
Open Access | Times Cited: 277
The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients
Apurva Hariharan, Abdul Rahman Hakeem, Subathra Radhakrishnan, et al.
Inflammopharmacology (2020) Vol. 29, Iss. 1, pp. 91-100
Open Access | Times Cited: 269
COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?
Dâmaris Silveira, Jose Maria Prieto-Garcia, Fábio Boylan, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 251
Integrated intra‐ and intercellular signaling knowledge for multicellular omics analysis
Dénes Türei, Alberto Valdeolivas, Lejla Gul, et al.
Molecular Systems Biology (2021) Vol. 17, Iss. 3
Open Access | Times Cited: 243
Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening
Olga Abián, David Ortega-Alarcón, Ana Jiménez-Alesanco, et al.
International Journal of Biological Macromolecules (2020) Vol. 164, pp. 1693-1703
Open Access | Times Cited: 242
Chemokines and chemokine receptors during COVID-19 infection
Bariaa Khalil, Noha Mousaad Elemam, Azzam A. Maghazachi
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 976-988
Open Access | Times Cited: 215
COVID-19 and thrombosis: From bench to bedside
Mohammad Ali, Sarah A. Spinler
Trends in Cardiovascular Medicine (2020) Vol. 31, Iss. 3, pp. 143-160
Open Access | Times Cited: 204
T‐cell responses and therapies against SARS‐CoV‐2 infection
Salman M. Toor, Reem Saleh, Varun Sasidharan Nair, et al.
Immunology (2020) Vol. 162, Iss. 1, pp. 30-43
Open Access | Times Cited: 200
METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection
Na Li, Hui Hui, William A. Bray, et al.
Cell Reports (2021) Vol. 35, Iss. 6, pp. 109091-109091
Open Access | Times Cited: 200
The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options
Shalki Choudhary, Kajal Sharma, Om Silakari
Microbial Pathogenesis (2020) Vol. 150, pp. 104673-104673
Open Access | Times Cited: 198
An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays
Yasin Orooji, Hessamaddin Sohrabi, Nima Hemmat, et al.
Nano-Micro Letters (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 196
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
Yiyue Ge, Tingzhong Tian, Suling Huang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 188
HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19
Mingfu Tian, Weiyong Liu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 177
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions
Daniel Butler, Christopher Mozsary, Cem Meydan, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 175
Controlling Cytokine Storm Is Vital in COVID-19
Lu Tang, Zhinan Yin, Yu Hu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 173
SARS‐CoV‐2 infection as a trigger of autoimmune response
Maria Cristina Sacchi, Stefania Tamiazzo, Paolo Stobbione, et al.
Clinical and Translational Science (2020) Vol. 14, Iss. 3, pp. 898-907
Open Access | Times Cited: 154
JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy
Sairaj Satarker, Antriya Annie Tom, Roshitha Ann Shaji, et al.
Postgraduate Medicine (2020) Vol. 133, Iss. 5, pp. 489-507
Open Access | Times Cited: 150
Covid-19: Perspectives on Innate Immune Evasion
Nima Taefehshokr, Sina Taefehshokr, Nima Hemmat, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 148
Page 1 - Next Page

Scroll to top